NAYA Biosciences, Inc. Common Stock
IVF
Get informed when a big investor buys or sells
+ FollowMarket Cap$3.25M
Close$
Share Statistics
| Market cap | $3.25 Million |
|---|---|
| Enterprise Value | $5.48 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-219.56 |
| Beta | 2.32 |
| Outstanding Shares | 1,422,141 |
Return
| Return on Equity | -592.85% |
|---|---|
| Return on Assets | -184.12% |
| Return on Invested Capital | -348.97% |
Valuation & Multiples
| P/E Ratio | -0.1 |
|---|---|
| PEG | 0 |
| Price to Sales | 0.0 |
| Price to Book Ratio | 0.0 |
| Enterprise Value to Revenue | 0.47 |
| Enterprise Value to EBIT | -0.16 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 1.06 |
| Debt to Equity | 1 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 26, 2026
EPS Estimate
$-1.25
Average shareholder expectationRevenue Estimate
$1.98 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 13.50%▲ 13.50% |
|---|---|
| Total Invested | $522,383 |
| Investors Holding | 6▲ 6.00% |
ESG Score
No data
About NAYA Biosciences, Inc. Common Stock
33 employees
CEO: Steven M. Shum INVO Fertility, Inc., formerly known as NAYA Biosciences, Inc., is a healthcare services fertility company dedicated to expanding assisted reproductive technology (ART) care. The company focuses on building, acquiring, and operating fert...